This study aimed to model the precision of SARS-CoV-2 seroprevalence estimates.
Methods
Sample size and precision estimates were calculated using the normal approximation to the binomial distribution. The relationship between sample size and precision was visualized across a range of assumed SARS-CoV-2 seroprevalence from 2% to 75%.
Results
The calculation found that 2% precision was attainable by taking moderately sized sample sets when the expected seroprevalence of SARS-CoV-2 infection exceeds 2%. In populations with a low incidence of SARS-CoV-2 infection and an expected seroprevalence of less than 2%, larger samples are required for precise estimates.
Conclusions
Taking a sample of 177–1000 participants can provide precise prevalence estimates of SARS-CoV-2 infection in vaccinated and unvaccinated populations. Larger sample sizes are only necessary in low prevalence settings.